XML 50 R31.htm IDEA: XBRL DOCUMENT v3.24.1
Stock Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
The following summary reflects nonvested restricted stock unit activity and related information:

The following summary reflects nonvested restricted stock unit activity and related information:

 

        Weighted Average 
    Shares   Fair Value (a) 
             
 Outstanding, December 31, 2021       $ 
 Granted    224,288    15.42 
 Vested         
 Outstanding, December 31, 2022    224,288   $15.42 
 Granted    180,430    10.33 
 Vested    (145,700)   16.20 
 Forfeited    (54,201)   14.57 
 Outstanding, December 31, 2023    204,817   $10.61 

 

_______

(a)Shares are valued at the grant-date market price.

 

   2023 
      
Weighted Average grant date fair value of restricted stock units granted during the year, per share  $10.33 
Total fair value of restricted stock units vested during the year  $2,286,464 
The following table summarizes the weighted average fair value and assumptions for 2023 and 2022.

The estimated fair value of an option is calculated using a Black-Scholes option valuation model with the following assumption inputs: dividend yield, expected annual volatility, risk free interest rate and an expected life of the option. The following table summarizes the weighted average fair value and assumptions for 2023 and 2022.

 

   2023   2022 
           
Weighted average grant-date fair value of stock options  $4.52   $4.55 
Stock Options Valuation Assumptions:          
Risk-free interest rate   3.9%   1.6%
Dividend yield   0.0%   0.0%
Expected volatility   64.9%   56.0%
Expected option life (in years)   2.88    2.99 
Other pricing model inputs:          
Weighted average grant-date market prices of Empire stock (strike price)  $10.07   $11.80 
The following summary reflects stock option activity and related information:

The following summary reflects stock option activity and related information:

 

        Weighted Average 
    Options   Exercise Price 
             
 Outstanding, December 31, 2021    2,440,700   $2.19 
 Granted    249,000    11.80 
 Exercised    (310,000)   1.34 
 Outstanding, December 31, 2022    2,379,700   $3.31 
 Granted    533,000    10.07 
 Exercised    (355,000)   1.35 
 Forfeited    (492,319)   5.42 
 Outstanding, December 31, 2023    2,065,381   $4.89 

The following table summarizes information about stock options outstanding as of December 31, 2023:

The following table summarizes information about stock options outstanding as of December 31, 2023:

 

Range of Options Weighted Average Weighted Options Weighted
Exercise Outstanding Remaining Average Exercisable Average
Prices at 12/31/23 Contractual Life Exercise Price at 12/31/23 Exercise Price
           
$1.32 to $12.36 2,065,381 4.94 years $4.89 1,605,210 $3.09